menu
    • menu

    Company profile for Assertio Therapeutics

    NEW Drugs in Dev: 7
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are Assertio — an assertive, energetic, and empathetic pharmaceutical company built around the mission of advancing patient care. Formerly known as Depomed, we have transformed our company with a current focus on three FDA-approved products in our core areas of neurology, orphan, and specialty medicines, as we continue to identify, license, and develop new products that offer enhanced options for patients who may be under...
    We are Assertio — an assertive, energetic, and empathetic pharmaceutical company built around the mission of advancing patient care. Formerly known as Depomed, we have transformed our company with a current focus on three FDA-approved products in our core areas of neurology, orphan, and specialty medicines, as we continue to identify, license, and develop new products that offer enhanced options for patients who may be underserved by existing therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Assertio TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 South Saunders Road, Suite 300 Lake Forest, IL 60045
    Telephone
    Telephone
    224.419.7106
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.assertiotx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/assertio-therapeutics-inc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Assertio Updates Merger Agreement With Garda Therapeutics
    Assertio Updates Merger Agreement With Garda Therapeutics

    04 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-04/assertio-announces-amended-and-restated-merger-agreement-with-garda-therapeutics

    PHARMIWEB
    04 May 2026
    Share Share
    Assertio Announces Agreement To Be Acquired By Garda Therapeutics
    Assertio Announces Agreement To Be Acquired By Garda Therapeutics

    08 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-08/assertio-announces-agreement-to-be-acquired-by-garda-therapeutics

    PHARMIWEB
    08 Apr 2026
    Share Share
    Assertio Reports Fourth Quarter & Full Year 2025 Financial Result
    Assertio Reports Fourth Quarter & Full Year 2025 Financial Result

    16 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260316015407/en/Assertio-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results

    BUSSINESSWIRE
    16 Mar 2026
    Share Share
    Assertio Holdings Regains Nasdaq Listing Compliance Requirements
    Assertio Holdings Regains Nasdaq Listing Compliance Requirements

    12 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260112434688/en/Assertio-Holdings-Inc.-Regains-Compliance-With-Nasdaq-Listing-Requirements

    BUSINESSWIRE
    12 Jan 2026
    Share Share
    Assertio Publishes Rolvedon Same-Day Dosing Trial
    Assertio Publishes Rolvedon Same-Day Dosing Trial

    09 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260109405279/en/Assertio-Announces-Publication-of-Rolvedon-Same-Day-Dosing-Clinical-Trial

    BUSINESSWIRE
    09 Jan 2026
    Share Share
    Assertio Reports Third Quarter 2025 Financial Results
    Assertio Reports Third Quarter 2025 Financial Results

    10 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251110802048/en/Assertio-Reports-Third-Quarter-2025-Financial-Results

    BUSINESS WIRE
    10 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Assertio Therapeutics and get a quotation

    Assertio Therapeutics is a supplier offers 2 products (APIs, Excipients or Intermediates).

    Find Diclofenac bulk with DMF offered by Assertio Therapeutics

    Find Meloxicam bulk with DMF offered by Assertio Therapeutics

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search